Skip to main content

Table 1 Demographic and clinical characteristics of PsAID < 4 patients

From: Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study

 PsAID < 4, N (122)PsAID ≥ 4, N (101)P value
Male, n (%)70 (57.4)51 (50.5)NS
Age, mean (SD), year54.5 (12.7)51.7 (12.7)NS
BMI, mean (SD) (kg/m2)27.1 (3.9)26.3 (4.8)NS
CRP (mg/L), mean (SD)2.8 (3.3)4.6 (8.4)< 0.05
Comorbidities, n (%)70 (57.4)43 (42.6)NS
 Dyslipemia40 (32.8)29 (28.7)NS
 HBP33 (27.0)27 (26.7)NS
 Obesity30 (24.6)16 (15.8)NS
 DM12 (9.8)9 (8.9)NS
PsA clinical pattern, n (%)
 Axial3 (2.5)4 (4.0) 
 Peripheral107 (87.7)79 (78.2) 
 Mixed12 (9.8)18 (17.8) 
Dactylitis64 (52.5)47 (46.5)NS
Enthesitis45 (36.9)35 (34.7)NS
DIP45 (36.9)48 (47.5)NS
Familial history, n (%)
 Psoriasis60 (49.2)51 (50.5)NS
 PsA11 (9.0)16 (15.8)NS
Ankylosing spondylitis2 (1.6)0 (0.0)NS
PsA duration, mean (SD), years9.6 (7.9)9.7 (7.7)NS
Skin symptoms duration, mean (SD), years21.6 (14.5)22.9 (15.0)NS
Articular symptoms duration, mean (SD), years11.9 (8.7)12.6 (10.0)NS
Radiologic findings
 Erosions in hands, n (%)40 (32.8)43 (42.6)NS
 Erosions in feet, n (%)33 (27.0)32 (31.7)NS
  1. BMI body mass Index, CRP C-reactive protein, HBP high blood pressure, DIP distal interphalangeal joint disease, DM diabetes mellitus, SD standard deviation, NS non-significant